KHN Morning Briefing

Summaries of health policy coverage from major news organizations.

House And Senate Negotiators Reaching Agreement On Compounding Pharmacy Legislation

The measure would apply uniform national standards to pharmacy compounding while enacting a track-and-trace system to ensure the safety of drugs throughout the supply chain.

The Hill: Lawmakers Strike Agreement On Compounding Pharmacy Regulation
Health policy leaders in the House and Senate announced an agreement on legislation to strengthen regulation of non-traditional compounding pharmacies, which have been tied to several deadly outbreaks in the last year. Lawmakers said the new bill would apply uniform national standards to pharmacy compounding while enacting a track-and-trace system to ensure drugs are safe throughout the supply chain. Currently, a patchwork of state and federal regulations complicates oversight of drug compounders, who either customize medications on a prescription-by-prescription basis or produce drugs in large quantities like a manufacturer (Viebeck, 9/25).

Reuters: U.S. Congressional Panels Agree On Bill To Regulate Drug Compounding
The bill, called the Drug Quality and Security Act, comes in response to a deadly outbreak last year of fungal meningitis that killed more than 50 people and was traced to a tainted steroid sold by the New England Compounding Center in Framingham, Massachusetts. The legislation is expect to pass smoothly and quickly through the full House and Senate (9/25).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.